Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 11, 2022
Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, et al.
Clinical Pharmacology in Drug Development
|
March 27, 2025
Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P-Glycoprotein Inhibition
Hongxia Jia, T Eric Ballard, Liming Zhang, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
May 13, 2014
Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012
Manuela G Neuman, Lawrence Cohen, Samir Zakhari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 22, 2024
Metabolism and Excretion of [<sup>14</sup>C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects
Hao Chen, Abhi Shah, Suguru Kato, et al.
Ear and Hearing
|
March 9, 2002
Threshold, comfortable level and impedance changes as a function of electrode-modiolar distance
Elaine Saunders, Lawrence Cohen, Antje Aschendorff, et al.
International Journal of Hepatology
|
April 25, 2012
Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C
Manuela G Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 14, 2009
Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report
Diane Wild, Sonya Eremenco, Isabelle Mear, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 9, 2020
Biotransformation Pathways and Metabolite Profiles of Oral [<sup>14</sup>C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
Sandeepraj Pusalkar, Xiaofei Zhou, Yuexian Li, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
May 1, 2007
Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides
Manuela G Neuman, Neil H Shear, Izabella M Malkiewicz, et al.
Molecules (Basel, Switzerland)
|
October 28, 2023
Radiosynthesis and Early Evaluation of a Positron Emission Tomography Imaging Probe [<sup>18</sup>F]AGAL Targeting Alpha-Galactosidase A Enzyme for Fabry Disease
Talakad G Lohith, Charalambos Kaittanis, Anthony P Belanger, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 11, 2022
Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, et al.
Clinical Pharmacology in Drug Development
|
March 27, 2025
Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P-Glycoprotein Inhibition
Hongxia Jia, T Eric Ballard, Liming Zhang, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
May 13, 2014
Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012
Manuela G Neuman, Lawrence Cohen, Samir Zakhari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 22, 2024
Metabolism and Excretion of [<sup>14</sup>C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects
Hao Chen, Abhi Shah, Suguru Kato, et al.
Ear and Hearing
|
March 9, 2002
Threshold, comfortable level and impedance changes as a function of electrode-modiolar distance
Elaine Saunders, Lawrence Cohen, Antje Aschendorff, et al.
International Journal of Hepatology
|
April 25, 2012
Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C
Manuela G Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 14, 2009
Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report
Diane Wild, Sonya Eremenco, Isabelle Mear, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 9, 2020
Biotransformation Pathways and Metabolite Profiles of Oral [<sup>14</sup>C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
Sandeepraj Pusalkar, Xiaofei Zhou, Yuexian Li, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
May 1, 2007
Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides
Manuela G Neuman, Neil H Shear, Izabella M Malkiewicz, et al.
Molecules (Basel, Switzerland)
|
October 28, 2023
Radiosynthesis and Early Evaluation of a Positron Emission Tomography Imaging Probe [<sup>18</sup>F]AGAL Targeting Alpha-Galactosidase A Enzyme for Fabry Disease
Talakad G Lohith, Charalambos Kaittanis, Anthony P Belanger, et al.
Page
of 5